A new staging system for hereditary transthyretin amyloidosis in the era of specific amyloidosis therapies
Abstract Objectives Currently, there are two prognosis staging systems validated for transthyretin amyloidosis (ATTR). We sought to develop a new staging system dedicated to hereditary transthyretin amyloidosis (ATTRv) patients on specific treatments. Methods and Results A total of 258 patients diag...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2025-12-01
|
| Seri Bilgileri: | ESC Heart Failure |
| Konular: | |
| Online Erişim: | https://doi.org/10.1002/ehf2.15414 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|